Bi-Flow is first bidirectional femoral arterial cannula validated for 29 days’ use LONDON--(BUSINESS WIRE)-- LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, ...
TCT 1544: Novel Percutaneous Intervention of Left Anterior Descending Bifurcation Aneurysm With Intrasaccular Flow Disruptor Receive the the latest news, research, and presentations from major ...
When newborn babies or children with heart or lung distress are struggling to survive, doctors often turn to a form of life support that uses artificial lungs. This treatment, called Extracorporeal ...
It’s a machine the size of a breadbox, but it’s making an enormous difference for patients at M Health Fairview University of Minnesota Medical Center. Now, the center is expanding what’s known as its ...
LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Bi-Flow Extracorporeal Membrane Oxygenation (ECMO) cannula earned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results